Scholarlink

<p>Dyslipidemia may affect pulmonary function through systemic inflammation and metabolic pathways; however, longitudinal evidence remains limited. This study examined the associations of baseline low-density lipoprotein (LDL) and high-density lipoprotein (HDL) cholesterol levels with subsequent rates of lung function decline and the incidence of airflow obstruction in a community-based observational cohort, Korean Genome and Epidemiology Study (KoGES). We analyzed 7381 participants without baseline airflow obstruction. LDL cholesterol was categorized as ≤ 130&#xa0;mg/dL (LDL<sub>low</sub>), 130–160&#xa0;mg/dL (LDL<sub>medium</sub>), and &gt; 160&#xa0;mg/dL (LDL<sub>high</sub>), while HDL cholesterol was classified as ≤ 50&#xa0;mg/dL (HDLlow) and &gt; 50&#xa0;mg/dL (HDL<sub>high</sub>). Annual changes in FEV₁ and FVC were estimated using linear mixed-effects models, and Cox proportional hazards models were applied to assess the risk of incident airflow obstruction. Compared with the LDL<sub>low</sub> group, participants in the LDL<sub>high</sub> group had a slower annual decline in FEV₁ (− 37.21 mL/year, 95% CI: −39.00 to − 35.43) versus (− 40.39 mL/year, 95% CI: −40.94 to − 39.84) and FVC (− 30.06 mL/year, 95% CI: −32.18 to − 27.94) versus (− 35.78 mL/year, 95% CI: −36.43 to − 35.13), respectively (both <i>p</i> &lt; 0.001). Higher LDL levels were significantly associated with a lower risk of incident airflow obstruction (adjusted HR: 0.71, 95% CI: 0.54–0.92). In contrast, higher HDL levels were associated with a faster FEV₁ decline (− 41.34 mL/year, 95% CI: −42.44 to − 40.24) compared with HDL<sub>low</sub> (− 37.84 mL/year, 95% CI −38.46 to − 37.22, <i>p</i> &lt; 0.001), but not with FVC decline or incident airflow obstruction. Higher baseline LDL cholesterol levels were associated with a slower decline in lung function and a lower risk of developing airflow obstruction, whereas higher HDL cholesterol levels were associated with an accelerated decline in FEV₁. These findings highlight complex, potentially bidirectional relationships between lipid metabolism and respiratory outcomes, warranting further mechanistic research. Importantly, these associations should not be interpreted as implying that high LDL is beneficial for general health.</p>

错误：搜索内容不能为空，请输入英文关键词
错误：关键词超出字数限制，请精简
高级检索

Associations of LDL and HDL cholesterol with lung function decline and risk of airflow obstruction in a community-based cohort

  • 期刊论文

  • 出版模式：

    开放获取

  • 发表日期：

    2025年12月18日

查看全文
  • Jaeeun Yoo,
  • Chin Kook Rhee,
  • Yong Suk Jo,
  • Joon Young Choi

摘要

Dyslipidemia may affect pulmonary function through systemic inflammation and metabolic pathways; however, longitudinal evidence remains limited. This study examined the associations of baseline low-density lipoprotein (LDL) and high-density lipoprotein (HDL) cholesterol levels with subsequent rates of lung function decline and the incidence of airflow obstruction in a community-based observational cohort, Korean Genome and Epidemiology Study (KoGES). We analyzed 7381 participants without baseline airflow obstruction. LDL cholesterol was categorized as ≤ 130 mg/dL (LDLlow), 130–160 mg/dL (LDLmedium), and > 160 mg/dL (LDLhigh), while HDL cholesterol was classified as ≤ 50 mg/dL (HDLlow) and > 50 mg/dL (HDLhigh). Annual changes in FEV₁ and FVC were estimated using linear mixed-effects models, and Cox proportional hazards models were applied to assess the risk of incident airflow obstruction. Compared with the LDLlow group, participants in the LDLhigh group had a slower annual decline in FEV₁ (− 37.21 mL/year, 95% CI: −39.00 to − 35.43) versus (− 40.39 mL/year, 95% CI: −40.94 to − 39.84) and FVC (− 30.06 mL/year, 95% CI: −32.18 to − 27.94) versus (− 35.78 mL/year, 95% CI: −36.43 to − 35.13), respectively (both p < 0.001). Higher LDL levels were significantly associated with a lower risk of incident airflow obstruction (adjusted HR: 0.71, 95% CI: 0.54–0.92). In contrast, higher HDL levels were associated with a faster FEV₁ decline (− 41.34 mL/year, 95% CI: −42.44 to − 40.24) compared with HDLlow (− 37.84 mL/year, 95% CI −38.46 to − 37.22, p < 0.001), but not with FVC decline or incident airflow obstruction. Higher baseline LDL cholesterol levels were associated with a slower decline in lung function and a lower risk of developing airflow obstruction, whereas higher HDL cholesterol levels were associated with an accelerated decline in FEV₁. These findings highlight complex, potentially bidirectional relationships between lipid metabolism and respiratory outcomes, warranting further mechanistic research. Importantly, these associations should not be interpreted as implying that high LDL is beneficial for general health.